We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

OctoPlus' Licensee Biolex Commences Phase IIb Study with Locteron

News   Apr 22, 2009

 
OctoPlus' Licensee Biolex Commences Phase IIb Study with Locteron
 
 
 

RELATED ARTICLES

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

Rotavirus Vaccine Cuts Infant Diarrhoea Deaths by a Third in Malawi

News

A major new study has shown that rotavirus vaccination reduced infant diarrhoea deaths by 34% in rural Malawi, a region with high levels of child deaths.

READ MORE

Highly Effective and Selective Molecule Developed to Fight Malaria

News

A novel laboratory-synthesized molecule is a strong candidate for the development of a new antimalarial drug.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE